ENTRY       D11043                      Drug
NAME        Ertugliflozin pidolate;
            Ertugliflozin L-pyroglutamic acid;
            Steglatro (TN)
PRODUCT     STEGLATRO (A-S Medication Solutions)
            STEGLATRO (A-S Medication Solutions)
            STEGLATRO (Merck Sharp & Dohme LLC)
FORMULA     C22H25ClO7. C5H7NO3
EXACT_MASS  565.1715
MOL_WEIGHT  565.9967
CLASS       Antidiabetic agent
             DG02044  Hypoglycemic agent
              DG01794  SGLT2 inhibitor
            Metabolizing enzyme substrate
             DG02924  UGT substrate
              DG03188  UGT1A9 substrate
              DG03190  UGT2B7 substrate
REMARK      ATC code: A10BK04
            Chemical structure group: DG02836
            Product (DG02836): D11043<US>
            Product (mixture): D11066<US> D11067<US>
EFFICACY    Antidiabetic, SGLT-2 inhibitor
  DISEASE   Type 2 diabetes mellitus [DS:H00409]
TARGET      SLC5A2 (SGLT2) [HSA:6524] [KO:K14382]
METABOLISM  Enzyme: UGT1A9 [HSA:54600], UGT2B7 [HSA:7364]
INTERACTION  
BRITE       Anatomical Therapeutic Chemical (ATC) classification [BR:br08303]
             A ALIMENTARY TRACT AND METABOLISM
              A10 DRUGS USED IN DIABETES
               A10B BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS
                A10BK Sodium-glucose co-transporter 2 (SGLT2) inhibitors
                 A10BK04 Ertugliflozin
                  D11043  Ertugliflozin pidolate &lt;US&gt;
            USP drug classification [BR:br08302]
             Blood Glucose Regulators
              Antidiabetic Agents
               Sodium-Glucose Co-Transporter 2 (SGLT2) Inhbitor
                Ertugliflozin
                 D11043  Ertugliflozin pidolate
             Cardiovascular Agents
              Sodium-Glucose Co-Transporter 2 Inhibitors (SGLT2i)
               Ertugliflozin
                D11043  Ertugliflozin pidolate
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01794  SGLT2 inhibitor
                DG02836  Ertugliflozin
                 D11043  Ertugliflozin pidolate
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                DG02836  Ertugliflozin
                 D11043  Ertugliflozin pidolate
               DG03190  UGT2B7 substrate
                DG02836  Ertugliflozin
                 D11043  Ertugliflozin pidolate
            Drug classes [BR:br08332]
             Antidiabetic agent
              DG01794  SGLT2 inhibitor
               D11043  Ertugliflozin pidolate
              DG02044  Hypoglycemic agent
               D11043  Ertugliflozin pidolate
            Target-based classification of drugs [BR:br08310]
             Transporters
              Solute carrier family
               SLC5
                SLC5A2 (SGLT2)
                 D11043  Ertugliflozin pidolate &lt;US&gt;
            New drug approvals in the USA [br08319.html]
             New molecular entities and new therapeutic biological products
              D11043
            New drug approvals in Europe [br08329.html]
             European public assessment reports (EPAR) authorised medicine
              D11043
            New drug approvals in the USA, Europe and Japan [br08328.html]
             Approval dates by FDA, EMA and PMDA
              D11043
            Drug metabolizing enzymes and transporters [br08309.html]
             Drug metabolizing enzymes
              D11043
            Drug groups [BR:br08330]
             Antidiabetic agent
              DG02044  Hypoglycemic agent
               DG01794  SGLT2 inhibitor
                DG02836  Ertugliflozin
             Metabolizing enzyme substrate
              DG02924  UGT substrate
               DG03188  UGT1A9 substrate
                DG02836  Ertugliflozin
               DG03190  UGT2B7 substrate
                DG02836  Ertugliflozin
DBLINKS     CAS: 1210344-83-4
            PubChem: 355052577
ATOM        39
            1   C8y C    15.7761  -17.5990
            2   C8x C    15.7761  -18.9312
            3   C8x C    16.8979  -19.5622
            4   C8y C    18.0899  -18.9312
            5   C8y C    18.0899  -17.5990
            6   C8x C    16.8979  -16.8978
            7   C1b C    19.2818  -16.8978
            8   C8y C    20.4738  -17.5990
            9   C8x C    20.4738  -18.9312
            10  C8x C    21.5957  -19.5622
            11  C8y C    22.7175  -18.9312
            12  C8x C    22.7175  -17.5990
            13  C8x C    21.5957  -16.8978
            14  X   Cl   19.2818  -19.5622
            15  O2a O    23.9095  -19.5622
            16  C1b C    25.0313  -18.9312
            17  C1a C    26.1532  -19.5622
            18  C1z C    14.5841  -16.8978
            19  O2x O    14.5841  -15.5656
            20  C1z C    13.3922  -14.8645
            21  C1y C    12.2703  -15.5656
            22  C1y C    12.2703  -16.8978
            23  C1y C    13.3922  -17.5990
            24  O1a O    13.3922  -18.9312
            25  O1a O    11.0783  -14.8645
            26  O1a O    11.0783  -17.5990
            27  C1b C    13.3922  -13.5323
            28  O1a O    14.5841  -12.8311
            29  C1x C    14.8646  -14.0231
            30  O2x O    16.2669  -15.9162
            31  C5x C    29.7178  -15.4386
            32  C1x C    30.1370  -16.7660
            33  C1x C    31.5343  -16.7659
            34  C1y C    32.0234  -15.5084
            35  N1x N    30.9055  -14.6700
            36  C6a C    33.2111  -14.7399
            37  O6a O    34.3988  -15.4386
            38  O6a O    33.2111  -13.3426
            39  O5x O    28.3903  -15.0194
BOND        42
            1     1   2 2
            2     2   3 1
            3     3   4 2
            4     4   5 1
            5     5   6 2
            6     1   6 1
            7     5   7 1
            8     7   8 1
            9     8   9 2
            10    9  10 1
            11   10  11 2
            12   11  12 1
            13   12  13 2
            14    8  13 1
            15    4  14 1
            16   11  15 1
            17   15  16 1
            18   16  17 1
            19   18   1 1 #Up
            20   18  19 1
            21   19  20 1
            22   20  21 1
            23   21  22 1
            24   22  23 1
            25   18  23 1
            26   23  24 1 #Down
            27   21  25 1 #Down
            28   22  26 1 #Up
            29   20  27 1 #Up
            30   27  28 1
            31   20  29 1 #Down
            32   18  30 1 #Down
            33   29  30 1
            34   31  32 1
            35   32  33 1
            36   33  34 1
            37   34  35 1
            38   31  35 1
            39   34  36 1 #Down
            40   36  37 1
            41   36  38 2
            42   31  39 2
///
